МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ
165,09 ₴
Price from pharmacies (Compendium)
Analogs of МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ
Find cheaper analogs and generic equivalents for МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ.
Wirkstoff: methylprednisolone
Produktübersicht
About МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ
МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ is a microencapsulated form of methylprednisolone, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is used to treat a variety of conditions, including severe allergic reactions, asthma, and certain types of arthritis.
Key Benefits & Uses
- Treatment of severe allergic reactions, including anaphylaxis
- Control of asthma symptoms and prevention of asthma attacks
- Reduction of inflammation and swelling in conditions such as rheumatoid arthritis and other autoimmune disorders
Active Ingredient & Action
Methylprednisolone works by mimicking the effects of cortisol, a hormone produced by the adrenal gland. It binds to glucocorticoid receptors in the body, leading to a decrease in the production of inflammatory chemicals and an increase in the production of anti-inflammatory chemicals. This results in a reduction of inflammation and swelling, as well as a suppression of the immune system's response to allergens and other foreign substances.
Important Notes
МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ should be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of side effects. Long-term use of methylprednisolone can lead to adrenal insufficiency, so it is crucial to taper the dose gradually when discontinuing treatment. Additionally, patients should be aware of the potential for increased susceptibility to infections and should report any signs of infection to their healthcare provider promptly.
Find in Pharmacies
Compare local prices and distance for МЕТИЛПРЕДНІЗОЛОН МІКРОНІЗОВАНИЙ.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.